Jeevan Scientific Technology

Jeevan Scientific Technology

63.00
-1.96
(-3.02%)
hide
Key Fundamentals
Add Ratio
Market Cap
99.80 Cr
EPS
-0.04
PE Ratio
-24.61
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
66.89
52 Week Low
32.85
PB Ratio
2.06
Debt to Equity
0.35
Forecast For
Actual

Company News

View All News
Caret
positive
Jeevan Scientific Technology Limited has scheduled an Extra-Ordinary General Meeting for November 12, 2025, to address several key corporate actions. The company plans to increase its authorized share capital from Rs 21 crores to Rs 25 crores and issue 35 lakh convertible warrants at Rs 40 per warrant to promoters and non-promoters, raising Rs 14 crores. Additionally, the company will issue 41.85 lakh equity shares at Rs 40 per share to non-promoters, raising Rs 16.74 crores. The total fundraising amounts to Rs 30.74 crores, intended for capital expenditure, working capital requirements, subsidiary operations, acquisition of API/formulation units, and general corporate purposes. The company will also adopt a new Memorandum of Association under the Companies Act 2013 and change its registered office state from Andhra Pradesh to Telangana. The relevant date for pricing is October 13, 2025, and the cut-off date for e-voting is November 5, 2025.
positive
Jeevan Scientific Technology Limited's Board approved multiple capital-raising initiatives during its meeting on October 15, 2025. The company plans to issue up to 35,00,000 convertible warrants at Rs. 40 per warrant to both promoters and non-promoters, raising approximately Rs. 14 crores. Additionally, the Board approved issuing up to 41,85,000 equity shares to non-promoters at Rs. 40 per share, generating around Rs. 16.74 crores. The convertible warrants must be converted to equity shares within 18 months or face forfeiture. The company also decided to increase its authorized share capital from Rs. 21 crores to Rs. 25 crores and adopt a new Memorandum of Association. Post-allotment, promoters will hold 38.37% while public shareholders will hold 61.63% of the company. An Extraordinary General Meeting is scheduled for November 12, 2025, to seek shareholder approval for these proposals. The Board also reconstituted various committees including Audit, Nomination and Remuneration, Stakeholder Relationship, Risk Management, and Corporate Social Responsibility committees.
negative
Jeevan Scientific Technology Reports Q2 2025 Loss, Approves Board Changes and ESOP GrantAug 14, 2025
Jeevan Scientific Technology Limited reported a standalone net loss of Rs 215.99 lakhs for Q2 2025 compared to a profit of Rs 160.08 lakhs in Q2 2024. Revenue declined to Rs 821.57 lakhs from Rs 1,251.66 lakhs year-over-year. The board approved reappointment of Krishna Kishore Kuchipudi as Managing Director for 3 years from April 2026 at Rs 9 lakhs monthly remuneration. Gollapinni Mallikarjuna was appointed as Independent Director, while Thammareddy Ravi resigned due to personal commitments. The company granted 3 lakh stock options to employees under ESOP Scheme 2016. Annual General Meeting is scheduled for September 27, 2025.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
660.90
#1 26,630.27
50.98
#1 3,714.20
3.77
#1 496
14.53
49.37
545.95
13,110.42
30.60
2,946.50
10.53
407
32.73
41.24
196.33
4,466.00
-24.36
17.60
-46.34
-161
-83.93
34.81
672.80
2,996.71
49.84
322.30
0.22
41
#1 112.87
42.56
23.77
351.64
8.31
10.20
-
1
76.32
93.61
101.41
238.76
-4.61
806.50
4.78
-56
34.67
59.13
63.00
#7 99.80
#1 -24.61
#6 47.50
#2 17.87
#6 0
#8 -420.00
91.29
19.13
26.30
33.09
84.00
5.00
2
-92.68
26.43
27.95
19.87
-1.50
1.96
#1 40.00
-13
-566.67
53.25
Growth Rate
Revenue Growth
17.87 %
Net Income Growth
-107.69 %
Cash Flow Change
248.44 %
ROE
-104.40 %
ROCE
-353.70 %
EBITDA Margin (Avg.)
29.32 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
3
0
9
5
4
5
4
5
6
5
5
6
5
6
8
8
4
3
6
9
9
5
13
16
16
16
19
21
17
11
8
10
8
11
8
10
11
13
12
13
10
9
Expenses
3
0
7
4
4
4
3
4
4
5
4
5
4
5
6
6
5
5
6
6
14
5
7
8
11
10
12
14
14
9
8
9
9
8
8
9
10
10
9
10
10
11
EBITDA
1
0
2
1
-1
1
1
1
1
1
1
2
1
2
3
3
-1
-1
0
2
-5
1
6
9
5
6
7
7
3
2
-0
2
-1
2
1
1
1
3
3
2
-0
-1
Operating Profit %
20 %
0 %
16 %
19 %
-17 %
16 %
17 %
17 %
16 %
9 %
21 %
21 %
13 %
22 %
29 %
32 %
-15 %
-42 %
-6 %
23 %
-95 %
15 %
38 %
53 %
32 %
36 %
34 %
32 %
-18 %
12 %
-5 %
15 %
-13 %
20 %
7 %
10 %
9 %
25 %
22 %
17 %
-4 %
-20 %
Depreciation
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
1
1
2
2
2
2
2
2
Interest
0
0
1
0
0
0
0
0
0
0
1
1
0
0
1
1
0
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
Profit Before Tax
0
0
1
0
-1
0
0
0
1
0
0
0
0
1
1
1
-2
-3
-2
1
-7
-1
4
7
4
5
5
6
2
0
-2
0
-3
1
-1
-1
-1
2
1
0
-3
-4
Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0
0
-0
-1
-0
0
-1
-0
1
1
0
1
2
2
2
-0
-0
0
-0
0
-0
-0
0
1
1
0
-1
-1
Net Profit
0
0
1
0
-1
0
0
0
1
0
0
0
-0
0
1
1
-2
-2
-1
0
-6
-1
3
6
4
3
4
4
1
0
-1
0
-2
1
-1
-1
-1
1
0
0
-1
-3
EPS in ₹
0.70
0.00
1.50
0.25
-1.77
0.16
0.20
0.24
0.51
0.03
0.09
0.12
-0.05
0.26
0.93
0.52
-0.97
-1.37
-0.95
0.26
-3.56
-0.37
1.79
3.74
2.56
2.17
2.45
2.80
0.52
0.25
-0.78
0.04
-1.51
0.33
-0.39
-0.31
-0.47
0.66
0.16
0.03
-0.81
-2.03

Balance Sheet

Balance Sheet
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
20
31
49
61
54
66
78
66
68
78
Fixed Assets
9
16
28
33
31
27
19
25
27
35
Current Assets
11
14
21
25
18
34
54
29
25
29
Capital Work in Progress
0
0
0
0
0
0
0
2
3
5
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
12
15
21
29
23
39
59
39
38
39
Total Liabilities
20
31
49
61
54
66
78
66
68
78
Current Liabilities
8
9
17
21
23
23
22
11
9
12
Non Current Liabilities
8
5
10
8
8
8
5
6
10
16
Total Equity
4
17
22
32
23
35
51
48
49
50
Reserve & Surplus
-2
3
7
17
8
20
35
33
33
34
Share Capital
6
9
12
15
15
15
15
16
16
16

Cash Flow

Cash Flow
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
1
2
-2
4
24
-23
-6
-0
Investing Activities
-4
-9
-14
-8
-2
-1
-1
-7
-12
-16
Operating Activities
4
-6
6
4
0
5
20
-6
3
10
Financing Activities
0
15
10
6
0
-0
6
-10
2
5

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
38.11 %
38.11 %
38.11 %
38.11 %
36.15 %
36.47 %
36.47 %
36.85 %
38.44 %
38.48 %
38.48 %
38.48 %
38.70 %
38.70 %
38.70 %
37.84 %
38.05 %
38.05 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
48.08 %
45.99 %
46.82 %
46.70 %
48.56 %
48.38 %
44.89 %
44.65 %
42.87 %
42.89 %
45.98 %
45.51 %
45.50 %
45.34 %
45.75 %
45.91 %
42.99 %
42.75 %
Others
13.81 %
15.90 %
15.06 %
15.18 %
15.29 %
15.15 %
18.64 %
18.50 %
18.69 %
18.63 %
15.53 %
16.00 %
15.80 %
15.96 %
15.55 %
16.25 %
18.96 %
19.21 %
No of Share Holders
2,740
3,999
5,499
5,813
6,144
6,439
6,449
6,295
6,061
5,911
5,933
5,727
5,749
5,655
5,607
5,565
5,497
5,460

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.5 1.2 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.38 2.38 0.00 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
12 Nov 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
12 Nov 2025 55.77 64.96
08 Sept 2021 DIVIDEND Dividend
₹ 0.50 /share
07 Sept 2021 98.10 96.40
23 Sept 2022 DIVIDEND Dividend
₹ 1.20 /share
21 Sept 2022 83.05 66.35
09 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
09 Aug 2024 50.73 56.59
08 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Nov 2024 52.94 52.88
06 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2025 45.04 45.23
27 Mar 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
27 Mar 2025 43.01 41.38
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 41.03 40.32
14 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Aug 2025 39.36 42.31
27 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2025 38.41 35.00

Announcements

Extra-Ordinary General Meeting Of The Company To Be Held On Wednesday 12Th Day Of November 2025 At 10.00 A.M. Through Video Conference / Other Audio-Visual Means (VC/OAVM)5 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20187 days ago
Announcement under Regulation 30 (LODR)-Preferential Issue7 days ago
Board Meeting Outcome for Outcome Of Board Meeting Held On 15.10.20257 days ago
Board Meeting Intimation for Prior Intimation Of Board Meeting For Consideration Of Fund-Raising ProposalOct 10, 2025
Announcement under Regulation 30 (LODR)-RetirementOct 06, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Outcome Of 27Th Annual General Meeting Held On 27Th September2025.Sep 27, 2025
Closure of Trading WindowSep 25, 2025
Intimation Of Book Closure And Cut-Off Date For The 27Th Annual General Meeting Of Jeevan Scientific Technology Limited.Sep 05, 2025
Annual General Meeting Of The Company Is Scheduled To Be Held On Saturday 27Th Day Of September 2025 At 10.00 A.M Through Video Conference VC / Other Audio-Visual Means.Sep 05, 2025
Reg. 34 (1) Annual Report.Sep 05, 2025
Reg. 34 (1) Annual Report.Sep 05, 2025
Annual General Meeting Of The Company Is Scheduled To Be Held On Saturday 27Th Day Of September 2025 At 10.00 A.M Through Video Conference "VC" I Other Audio-Visual Means.Sep 05, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorAug 14, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 14, 2025
Un Audited Financial Results For The Quarter Ended 30.06.2025Aug 14, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 14.08.2025Aug 14, 2025
Board Meeting Intimation for The Meeting To Be Held On 14.08.2025Aug 06, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 07.08.2025Aug 01, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 19, 2025
Closure of Trading WindowJun 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 31, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 30, 2025
Audited Results (Standalone And Consolidated) Of The Company For The Quarter And Year Ended 30.05.2025May 30, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 30.05.2025May 30, 2025
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 30.05.2025May 26, 2025
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 30, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 15, 2025
Information About Successful Completion Of Inspection Of JSTL Clinical And Bioanalytical Facilities By CDSCO (Central Drugs Standard Control Organisation) Under Regulation 30 Of SEBI (LODR) Regulations 2015.Apr 09, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 27, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMMar 27, 2025
Closure of Trading WindowMar 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 17, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 05, 2025
Notice Of Extra-Ordinary General Meeting To Be Held On 27Th March 2025 At 10:00 AM.Mar 03, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 01.03.2025Mar 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 08, 2025
Copy Of News Paper Cuttings Of The Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024.Feb 08, 2025
Integrated Filing (Financial)Feb 06, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 06, 2025
Integrated Filing (Financial)Feb 06, 2025
Un Audited Results For The Quarter And Nine Months Ended 31.12.2024Feb 06, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 06.02.2025Feb 06, 2025
Board Meeting Intimation for Intimation For The Board Meeting To Be Held On 06.02.2025.Jan 30, 2025

Technical Indicators

RSI(14)
Overbought
82.88
ATR(14)
Volatile
3.94
STOCH(9,6)
Overbought
94.99
STOCH RSI(14)
Overbought
89.49
MACD(12,26)
Bullish
2.64
ADX(14)
Strong Trend
46.05
UO(9)
Bearish
76.93
ROC(12)
Uptrend And Accelerating
66.44
WillR(14)
Overbought
-5.86